Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
BG-89894
BEONE MEDICINES AUS PTY LTD
Advanced or Metastatic MTAP-deleted Solid Tumors
1 trial -
BG-C0902
BEONE MEDICINES AUS PTY LTD
Solid Tumors
1 trial -
BG-C0979
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BG-C137
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BG-C477
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumors
1 trial -
BG-C9074
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-15025
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-24714
BEONE MEDICINES AUS PTY LTD
Solid Tumor, Adult
1 trial -
BGB-26808
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-43395
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-53038
BEONE MEDICINES AUS PTY LTD
Metastatic Solid Tumors
1 trial -
BGB-58067
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-A3055
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-B455
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-C354
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-R046
BEONE MEDICINES AUS PTY LTD
Solid Tumor
1 trial -
BGM-2121
Chongqing Precision Biotech Co., Ltd
Advanced Solid Tumors
1 trial -
BI 3011441
Boehringer Ingelheim
Solid Tumors, KRAS Mutation
1 trial -
BMS-986500
Bristol-Myers Squibb
Advanced Solid Tumor
1 trial -
BNT211, BNT211, BNT211, BNT211
BioNTech SE
Solid Tumors
1 trial -
BNT314
BioNTech SE
Advanced or metastatic malignant solid tumors
1 trial -
BPT567
BRIGHT MINDS BIOSCIENCES INC.
Advanced Solid Tumors
1 trial -
Beamion LUNG-1: A study to test different doses of zongertinib in people with different types of advanced cancer (solid tumours with changes in the HER2 gene)
Boehringer Ingelheim
Solid tumours with HER2 aberrations, Non-small cell lung cancer
1 trial -
Biological: PD-1
Hospital Authority, Hong Kong
Advanced Solid Tumor
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources